Householder Group Estate & Retirement Specialist’s Takeda Pharmaceutical TAK Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$0	Hold	70	–	–	﹤0.01%	1142
2024 Q3	$0	Buy	+70	New	+$993	﹤0.01%	1321
2024 Q2	–	Sell	-70	Closed	-$972	–	1332
2024 Q1	$972	Hold	70	–	–	﹤0.01%	1115
2023 Q4	$0	Sell	70 -75	-52%	-$1.06K	﹤0.01%	1323
2023 Q3	$2.24K	Buy	+145	New	+$2.25K	﹤0.01%	1051
2023 Q1	$2K	Buy	+145	New	+$2.31K	﹤0.01%	1100
2022 Q4	–	Sell	-145	Closed	-$1K	–	1046
2022 Q3	$1K	Buy	+145	New	+$2.02K	﹤0.01%	1053

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's TAK Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist held its Takeda Pharmaceutical (TAK) position steady in Q4 2024 at 70 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Householder Group Estate & Retirement Specialist first reported a position in TAK in Q3 2022 and has held it in 7 quarters since. The position peaked at $2.24K in Q3 2023. 300 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

Householder Group Estate & Retirement Specialist held 70 shares of Takeda Pharmaceutical worth $0 as of Q4 2024.
Householder Group Estate & Retirement Specialist left its Takeda Pharmaceutical share count unchanged in Q4 2024.
Takeda Pharmaceutical made up ﹤0.01% of Householder Group Estate & Retirement Specialist's portfolio in Q4 2024, its #1142 holding.
Householder Group Estate & Retirement Specialist first reported a position in Takeda Pharmaceutical in Q3 2022 and has held it in 7 quarters since.
Householder Group Estate & Retirement Specialist's Takeda Pharmaceutical position peaked at $2.24K in Q3 2023.
300 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.